================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 10-Q

         Quarterly  report  pursuant  to Section  13 or 15(d) of the  Securities
         Exchange Act of 1934. For the quarter ended March 31, 1996.

                         Commission file number 1-11388


                                PLC SYSTEMS INC.
             (Exact name of registrant as specified in its charter)


BRITISH COLUMBIA, CANADA                                04-3153858
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
  incorporation or organization)

113 CEDAR STREET, SUITE S-2, MILFORD, MASSACHUSETTS                    01757
(Address of principal executive offices)                             (Zip Code)

       Registrant's telephone number, including area code: (508) 478-5991



Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. YES  X  NO    .
                                       ---    ---


                      APPLICABLE ONLY TO CORPORATE ISSUERS:


Indicate  the  number of shares  outstanding  of each of the  issuer's  class of
common stock, as of the latest practical date.

           Class                                     Outstanding at May 14, 1996
  Common Stock, no par value                                  16,436,281










================================================================================



                                PLC SYSTEMS INC.

                                      INDEX





Part I.  Financial Information:
                                                                                                       
         Item 1.

               Consolidated Balance Sheets.................................................................3

               Consolidated Statements of Operations.......................................................4

               Consolidated Statements of Cash Flows.......................................................5

               Notes to Consolidated Financial Statements..................................................6


         Item 2.  Management's Discussion and Analysis
                    of Financial Condition and Results of Operations.....................................7-9


Part II.     Other Information:

         Item 1.    Legal Proceedings.....................................................................10

         Item 2.    Changes in Securities.................................................................10

         Item 3.    Defaults by the Company Upon its Senior Securities....................................10

         Item 4.    Submission of Matters to a Vote of Security Holders...................................10

         Item 5.    Other Information.....................................................................10

         Item 6.    Exhibits and Reports on Form 8-K..................................................... 10










                                       -2-





ITEM 1.  FINANCIAL STATEMENTS
- - --------------------------------------------------------------------------------


                                                 PLC SYSTEMS INC.
                                            CONSOLIDATED BALANCE SHEETS
                                                  (In thousands)




                                                                            March 31,          December 31,
                                                                              1996                 1995
                                                                           (Unaudited)
                                                      ASSETS
                                                                                                  
Current assets:
    Cash and cash equivalents..........................................      $  4,183             $     704
    Short-term investments.............................................        11,496                 6,500
    Accounts receivable, net...........................................         1,811                 6,749
    Inventories, net ..................................................         1,961                 1,789
    Prepaid expenses and other current assets..........................           778                   488
                                                                             --------               -------
        Total current assets...........................................        20,229                16,230

Equipment, furniture and leasehold improvements, net  .................         1,722                 1,692
Other assets...........................................................           312                   368
                                                                              -------               -------
       Total assets....................................................       $22,263               $18,290
                                                                              =======               =======


                                       LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
    Accounts payable...................................................      $    972             $     546
    Accrued clinical costs.............................................         1,178                   854
    Accrued compensation...............................................           260                   777
    Deferred revenue...................................................           118                   166
    Other accrued liabilities..........................................           377                   346
                                                                             --------              --------
       Total current liabilities.......................................         2,905                 2,689

Deferred revenue.......................................................           278                    61
Capital lease obligations .............................................            29                    32
Commitments and contingencies

Stockholders' equity:
Common stock, no par value,  25,000 shares authorized,  16,419
       and 15,944 shares issued and outstanding in 1996 and 1995,
       respectively....................................................        53,675                51,411
Accumulated deficit....................................................       (34,312)              (35,589)
Foreign currency translation...........................................          (312)                 (314)
                                                                            ---------            ----------
                                                                               19,051                15,508
                                                                             --------              --------
Total liabilities and stockholders' equity.............................       $22,263               $18,290
                                                                              =======               =======




     The  accompanying  notes are an integral part of the consolidated financial statements.


                                       -3-





                                                 PLC SYSTEMS INC.
                                       CONSOLIDATED STATEMENTS OF OPERATIONS
                                       (In thousands, except per share data)



                                                                                       Three Months Ended
                                                                                             March 31,
                                                                                    1996              1995
                                                                                                   
Revenues:
     Product sales.....................................................             $ 4,197           $2,714
     Placement and service fees........................................                 632              154
                                                                                   --------         --------
        Total revenues.................................................               4,829            2,868

Cost of revenues:
   Product sales.......................................................               1,086            1,064
   Placement and service fees..........................................                 304               26
                                                                                   --------        ---------
        Total cost of revenues.........................................               1,390            1,090
                                                                                    -------          -------

Gross profit...........................................................               3,439            1,778

Operating expenses:
   Selling, general and administrative.................................               1,451            1,017
   Research and development............................................                 759              755
                                                                                   --------         --------
      Total operating expenses.........................................               2,210            1,772
                                                                                    -------          -------

Income from operations.................................................               1,229                6

Other income:
    Interest income, net...............................................                 138              157
    Gain (loss) from foreign currency, net.............................                 (71)              -
                                                                                   --------       ---------
                                                                                         67              157
                                                                                   --------       ---------

Income before income taxes.............................................               1,296              163
Provision for income taxes.............................................                  19               -
                                                                                  ---------       ---------
Net income.............................................................              $1,277           $  163
                                                                                     ======           ======

Net income per share...................................................                $.07             $.01

Shares used to compute net income per share............................              17,030           17,501






      The  accompanying  notes are an integral part of the consolidated financial statements.


                                       -4-





                                                 PLC SYSTEMS INC.
                                       CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                  (In thousands)



                                                                                          Three Month Ended
                                                                                               March 31,
                                                                                    1996               1995
                                                                                                   
Operating activities:
   Net income .........................................................             $  1,277         $   163

     Adjustments  to reconcile  net income to net cash provided (used)
     for operating activities:
      Depreciation and amortization....................................                 236               78
       Change in assets and liabilities:
         Decrease (increase) in accounts receivable....................               4,923           (2,160)
         Increase in inventory.........................................                (194)            (197)
         (Increase) decrease in prepaid expenses and other assets .....                (275)              29
         Increase in accounts payable..................................                 431              251
         Increase (decrease) in deferred revenue.......................                 171              (17)
         (Decrease) increase in accrued liabilities....................                (163)             710
                                                                                  ---------         --------
Net cash provided (used) for operating activities......................               6,406           (1,143)

Investing activities:
   Purchase of short-term investments .................................             (11,496)            (300)
   Maturities of short-term investments................................               6,500               -
   Purchase of fixed assets............................................                (271)             (65)
                                                                                  ---------         --------
Net cash used for investing activities.................................              (5,267)            (365)

Financing activities:
   Net proceeds from sales of shares...................................               2,184               -
   Repayment of stockholder notes......................................                  79               56
   Principal payments on capital lease obligations.....................                  (2)              (2)
                                                                                ------------       ---------
Net cash provided by financing activities..............................               2,261               54

Effect of exchange rate changes on cash and cash equivalents..........                   79               21
                                                                                -----------        ---------
Net (decrease) increase in cash and cash equivalents...................               3,479           (1,433)

Cash and cash equivalents at beginning of period.......................                 704            3,699
                                                                                 ----------          -------
Cash and cash equivalents at end of period.............................            $  4,183           $2,266
                                                                                   ========           ======




         The  accompanying  notes are an integral part of the consolidated financial statements.


                                       -5-





                                PLC SYSTEMS INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS




1.       BASIS OF PRESENTATION

         The balance  sheet as of March 31, 1996 and the statement of operations
and cash flows for the three months ended March 31, 1996 and 1995 are  unaudited
and  in  the  opinion  of  management,  all  adjustments  necessary  for a  fair
presentation of such financial  statements have been recorded.  Such adjustments
consisted only of normal recurring items.

         Certain  information  and  footnote  disclosures  normally  included in
financial  statements  prepared in accordance with generally accepted accounting
principles have been condensed or omitted.  The year-end  balance sheet data was
derived  from audited  financial  statements,  but does not include  disclosures
required by generally accepted accounting principles. It is suggested that these
interim  financial  statements be read in  conjunction  with the Company's  most
recent Form 10-K and Annual Report as of December 31, 1995.

2.       NET INCOME PER SHARE

         Net income per share is calculated using the weighted average number of
shares and share equivalents  outstanding  during the period.  Share equivalents
consist of stock options and stock warrants.

3.       INVENTORY

         Inventories consist of the following (in thousands):



                                                                        March 31,        December 31,
                                                                          1996               1995
                                                                                          
               Raw materials  . . . . . . . . . . . . . . . . . . . . .  $1,053             $   644
               Work in process . . . . . . . . . . . . . . . . . . . .      337                  56
               Finished goods . . . . . . . . . . . . . . . . . . . . .     571               1,089
                                                                       --------             -------
                                                                         $1,961              $1,789
                                                                         ======              ======


4.       STOCK WARRANTS

         On March 8, 1996,  the Company's  Form S-3 to register the common stock
underlying  the warrants  issued to the  Company's  1992  underwriters  and 1994
placement   agent  was  declared   effective  by  the  Securities  and  Exchange
Commission.  The warrant issued to the underwriters provided for the purchase of
145,000  shares at $6.00 per share and  72,500  shares at $4.80 per  share.  The
warrant  issued to the  placement  agent  provided  for the  purchase of 150,000
shares at $3.94 per share. At March 31, 1996, all of the placement agents shares
and all but  16,770 of the  underwriters  shares had been  purchased  generating
approximately $1,660,000 in proceeds.

                                       -6-





ITEM 2.
- - --------------------------------------------------------------------------------


                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS



OVERVIEW

        The Company has two marketing strategies for selling the Heart Laser and
its related components and sterile kits; placement and sales. In countries where
health  care  is  reimbursed  by the  government  or by  private  insurers,  the
Company's  strategy is to be reimbursed  for the use of the Heart Laser on a per
procedure basis under a contractual  agreement whereby the customer commits to a
minimum number of procedures on a yearly basis.  These  contracts  typically run
for a  minimum  of  three  years  and  allow  for the  customer  to  exceed  the
contractual minimums.  These contracts,  referred to as placement contracts, are
preferred  to the sale  strategy  as the  Company  believes  that the  potential
revenue  stream is greater and more  profitable.  Sterile  handpieces  and other
disposables are included in the per procedure fee.

        In countries  where health care is not  reimbursed by the  government or
insurance,  or where  credit  risk is high,  the Heart  Laser is sold as capital
equipment and the related  sterile  handpieces  and other  disposables  are sold
separately  for each  procedure.  The Company  sells Heart  Lasers  directly and
through distributors. These sales are classified as product sales.

RESULTS OF OPERATIONS

        Total  revenues  of  $4,829,000  for the  quarter  ended  March 31, 1996
increased  $1,961,000 or 68% when compared to total  revenues of $2,868,000  for
the quarter ended March 31, 1995. For the quarter ended March 31, 1996,  product
sales of $4,197,000  increased  $1,483,000 or 54% when compared to product sales
of $2,714,000 for the quarter ended March 31, 1995. This increase was the result
of the sale of six Heart  Lasers  for the  quarter  ended  March  31,  1996 when
compared to four Heart Lasers sold for the quarter ended March 31, 1995.

        Placement  and service  revenue of $632,000 for the quarter  ended March
31, 1996 increased  $478,000 over placement and service  revenue of $154,000 for
the quarter ended March 31, 1995.  This increase  reflects the twelve  placement
contracts  in effect  as of March  31,  1996 as  compared  to the two  placement
contracts  in effect as of March 31, 1995.  The Company  shipped one Heart Laser
under a placement  contract in the quarter  ended March 31,  1996.  In addition,
there were  $25,000 of  service  fees in the  quarter  ended  March 31,  1996 as
compared to $9,500 for the quarter ended March 31, 1995.

        Total gross profit  increased to  $3,439,000  or 71% of revenues for the
quarter ended March 31, 1996 as compared with  $1,778,000 or 62% of revenues for
the quarter ended March 31, 1995.  This  improvement  is the result of six Heart
Lasers being sold directly to customers by the Company's European  subsidiary in
the quarter ended March 31, 1996 as compared with four Heart

                                       -7-





                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                                   (Continued)



Lasers;  two of which  were sold  directly  and two of which  were sold  through
distributors in the quarter ended March 31, 1995.  Heart Lasers sold directly to
customers  typically  carry a  higher  gross  profit  than  those  sold  through
distributors.

        Selling,  general  and  administrative  expenses of  $1,451,000  for the
quarter  ended  March 31, 1996  increased  $434,000  or 43% when  compared  with
$1,017,000  for the quarter ended March 31, 1995.  The majority of this increase
is the direct result of the Company's expanded international sales operations in
Europe and Asia Pacific which accounted for approximately $168,000 or 39% of the
increase  coupled with  increased  salary expense  related to expanded  staffing
domestically,  increased  commissions  associated  with higher  sales volume and
increased consulting expenses.

        Research and development  expenditures of $759,000  increased  $4,000 or
less than 1% for the quarter  ended March 31, 1996 when  compared  with $755,000
for the quarter ended March 31, 1995.  This small  increase is the net result of
the offset between  increased  salary expense for expanded  staffing offset by a
small decrease in spending for scientific subsidies.

        Other income of $67,000 for the quarter  ended March 31, 1996  decreased
$90,000 or 57% when  compared to $157,000 for the quarter  ended March 31, 1995.
This decrease is the result of lower interest income due to lower interest rates
throughout  the quarter  ended  March 31, 1996 as compared to the quarter  ended
March 31, 1995  coupled  with a $71,000  foreign  currency  loss  related to the
Company's European subsidiary.

        Although the Company has sufficient net operating loss  carryforwards to
offset  income taxes for the quarter  ended March 31, 1996,  the  provision  for
income taxes  represents  the tax liability  under the  alternative  minimum tax
regulations  which cannot be offset by net operating loss  carryforwards.  There
was no provision for income tax for the quarter ended March 31, 1995.

        Net  income  of  $1,277,000  and net  income  per  share of $.07 for the
quarter ended March 31, 1996 reflect the positive  impact of the number of Heart
Lasers sold directly by the Company's  European  subsidiary when compared to net
income of $163,000 and net income per share of $.01 for the quarter  ended March
31,  1995.  The Company  believes  that the number and mix of Heart  Lasers sold
versus shipped under placement contracts will vary from quarter to quarter. This
will  impact  the  Company's  results  of  operations  prior to receipt of major
regulatory approvals. The Company prefers to use the placement contract strategy
whenever  possible as it believes that the potential long term revenue stream is
greater and more profitable.  International  health care  reimbursement does not
always make this placement strategy practicable outside the United States.


LIQUIDITY AND CAPITAL RESOURCES

        At March  31,  1996,  the  Company  had cash  and  cash  equivalents  of
$4,183,000 and short-term


                                       -8-





                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                                   (Continued)



investments  of  $11,496,000.  At April 30, 1996,  the Company had cash and cash
equivalents of $3,136,000 and short-term investments of $11,451,000.

         During  the  quarter  ended  March  31,  1996,  the  Company   received
approximately $1,660,000 in proceeds from the exercise of stock warrants coupled
with  $524,000 in proceeds  from the exercise of stock  options and $79,000 from
the repayment of  shareholder  loans.  Cash provided by operations  approximated
$6,400,000 principally from the collection of the $5,700,000 receivable from the
IMATRON Japan Contract and the quarterly profit of $1,277,000.  As a result, the
Company   invested  an  additional   $5,000,000   in  short  term   investments.
Approximately  $271,000  was  used to  acquire  capital  equipment,  principally
related to an investment in the placement laser shipped to Spain.

         The Company believes that existing cash balances are sufficient to meet
working  capital and  capital  expenditure  requirements  through  fiscal  1997.
However,  unanticipated decreases in operating revenues or increases in expenses
may adversely impact the Company's cash position. In the future, the Company may
seek  additional   financing  through  issuance  and  sale  of  debt  or  equity
securities,  bank financing,  joint ventures or other means. The availability of
such  financing  and the  reasonableness  of any related  terms in comparison to
market conditions cannot be assured.

         The Company believes that periodic  operating losses are possible until
such time as the Company  receives its PMA from the FDA for the Heart Laser. The
Company  submitted its PMA  application in April 1995.  Although the Heart Laser
has been granted "expedited  review" status by the Food and Drug  Administration
("FDA"),  given the  current  uncertainties  of the time  required by the FDA to
approve a Premarket  Approval  ("PMA")  application,  the Company cannot project
when, if at all, such approval would be granted.  Until PMA approval,  continued
profitability will likely be determined by the number of international shipments
and the related mix of sales and placements.  In addition, the Company must also
successfully  obtain  approval  from the FDA for sale of the Heart  Laser in the
United  States,  obtain  regulatory  approval from and market the Heart Laser in
certain  additional  foreign  markets,  and convince health care  professionals,
third party payors and the general  public of the medical and economic  benefits
of the  Heart  Laser.  No  assurance  can be  given  that  the  Company  will be
successful  in  marketing  the Heart Laser or that the  Company  will be able to
operate profitably on a consistent quarterly basis.


                                       -9-





                                PLC SYSTEMS INC.
                            Part II Other Information



ITEM 1.   LEGAL PROCEEDINGS.

                  None

ITEM 2.   CHANGES IN SECURITIES

                  None

ITEM 3.      DEFAULTS BY THE COMPANY UPON ITS SENIOR SECURITIES

                  None

ITEM 4.      SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

                  None

ITEM 5.      OTHER INFORMATION

                  None

ITEM 6.      EXHIBITS AND REPORTS ON FORM 8-K

             a.) The following exhibits are filed herewith:

Exhibit
   No.                     Title

  10a        Employee  Agreement  by  and  between  the  Company and Patricia L.
             Murphy.

  10b        1993 Formula Stock Option Plan, as amended.

  11         Statement re Computation of Income Per Share.

  27         Financial Data Schedule.

             b.) Reports on Form 8-K. The Company filed a Current Report on Form
                 8-K on March 1, 1996,  reporting  information  contained in the
                 Company's  press release with respect to its financial  results
                 for the fourth quarter and year ended December 31, 1995.

                                      -10-





                                PLC SYSTEMS INC.
                            Part II Other Information
                                   (Continued)






SIGNATURES

       Pursuant to the requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.




                                         PLC SYSTEMS INC.
                                         Registrant



Date:    May 15, 1996                    /s/  M. Lee Hibbs
      -------------------                -------------------
                                         M. Lee Hibbs
                                         (President and Chief Executive Officer)



Date:    May 15, 1996                    /s/  Patricia L. Murphy
      --------------------               -------------------------
                                         Patricia L. Murphy
                                         (Chief Financial Officer)

                                      -11-